Asaf Danziger
2014
In 2014, Asaf Danziger earned a total compensation of $1.7M as Chief Executive Officer at NovoCure.
Compensation breakdown
| Non-Equity Incentive Plan | $313,568 |
|---|---|
| Option Awards | $448,161 |
| Salary | $696,174 |
| Other | $288,528 |
| Total | $1,746,431 |
Danziger received $696.2K in salary, accounting for 40% of the total pay in 2014.
Danziger also received $313.6K in non-equity incentive plan, $448.2K in option awards and $288.5K in other compensation.
Rankings
In 2014, Asaf Danziger's compensation ranked 5,095th out of 13,032 executives tracked by ExecPay. In other words, Danziger earned more than 60.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,095 out of 13,032 | 61st |
Division Manufacturing | 1,817 out of 4,965 | 63rd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 226 out of 731 | 69th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 128 out of 441 | 71st |
Industry Surgical and Medical Instruments and Apparatus | 68 out of 270 | 75th |
Source: SEC filing on March 24, 2016.
Danziger's colleagues
We found one more compensation record of an executive who worked with Asaf Danziger at NovoCure in 2014.
2014
Wilhelmus Groenhuysen
NovoCure